You now need to submit a Letter of Intent by May 29, 2026, to apply for this funding cycle. The research scope has also expanded to include pulmonary hypertension in the context of interstitial lung disease (ILD-PH). Finally, be sure to check the newly detailed eligibility criteria regarding specific career stages, prior funding limits, and the requirement for a strong mentor link.
Funder: Pulmonary Fibrosis Foundation
Due Dates: May 29, 2026: Letter of Intent deadline (PFF/PHA Joint Partner Award)
Funding Amounts: $100,000 over two years per award (includes up to 8% indirect costs)
Summary: Supports early-career researchers advancing innovative studies to improve understanding of pulmonary fibrosis.